Other OTC Pharmaceuticals - Montenegro

  • Montenegro
  • In Montenegro, the revenue generated in the market Other OTC Pharmaceuticals amounted to US$6.97m in 2024.
  • It is projected that the market will experience an annual growth rate of 1.23% (CAGR 2024-2029).
  • When compared to other countries worldwide, the in the United States generates the highest revenue in this market with a total of US$7,171.00m in 2024.
  • Considering the population of Montenegro, the per person revenue in 2024 amounts to US$11.14.
  • Montenegro's OTC Pharmaceuticals market is witnessing a rise in demand for alternative herbal remedies and traditional medicines.

Key regions: United States, Brazil, Europe, Canada, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals market in Montenegro is witnessing steady growth due to increasing customer preferences for self-medication, a growing trend in the global market.

Customer preferences:
Customers in Montenegro are increasingly opting for over-the-counter (OTC) pharmaceuticals for self-medication purposes. This can be attributed to the convenience, accessibility, and affordability of OTC products compared to prescription medications. With busy lifestyles and a desire for quick relief, consumers are seeking OTC remedies for common ailments such as cold and flu, headaches, and digestive issues. This shift in customer preferences towards self-care and self-medication is a global trend that is driving the growth of the Other OTC Pharmaceuticals market in Montenegro.

Trends in the market:
The Montenegrin market for Other OTC Pharmaceuticals is witnessing several trends that are shaping its development. Firstly, there is a growing demand for natural and herbal remedies. Consumers are becoming more health-conscious and are seeking products that are perceived as safer and more sustainable. This has led to an increase in the availability and popularity of natural OTC products in the market.Secondly, there is a rising trend of online purchasing of OTC pharmaceuticals. The convenience of online shopping and the ability to compare prices and read reviews have made e-commerce platforms a preferred channel for customers to purchase OTC products. This trend is further fueled by the COVID-19 pandemic, which has led to an increase in online shopping across various industries.

Local special circumstances:
Montenegro is a small market with a population of approximately 620,000 people. The country's healthcare system is relatively underdeveloped compared to Western European countries, which has led to a higher reliance on OTC pharmaceuticals for self-medication. The limited availability of healthcare services and long waiting times for doctor appointments have contributed to the preference for OTC remedies among Montenegrin consumers.

Underlying macroeconomic factors:
The Montenegrin economy has been growing steadily in recent years, leading to an increase in disposable income among the population. This has resulted in higher purchasing power and an ability to spend on healthcare products, including OTC pharmaceuticals. Additionally, the government has implemented policies to promote the development of the healthcare sector, including the expansion of pharmacies and the regulation of OTC products. These factors have created a favorable environment for the growth of the Other OTC Pharmaceuticals market in Montenegro.In conclusion, the Other OTC Pharmaceuticals market in Montenegro is experiencing growth due to increasing customer preferences for self-medication, the global trend of OTC usage, and local special circumstances such as limited healthcare services. The market is also influenced by trends such as the demand for natural remedies and the rise of online purchasing. The underlying macroeconomic factors, including a growing economy and supportive government policies, further contribute to the development of the market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)